Biotech organizations which can be unprofitable are at risk of not acquiring adequate cash to productively fund clinical reports and total regulatory filings to bring a fresh drug to market. With over 3 billion electrical vehicles (EVs) to the highway and three terawatt-several hours (TWh) of battery storage deployed while in the NZE in 2050, ba